✦ LIBER ✦

A377 Phase II Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)

✍ Scribed by Jagannath, S; Vij, R; Stewart, AK; Somlo, G; Jakubowiak, A; Reiman, T; Trudel, S; Taylor, J; Fuhrman, D; Cruickshank, S; Schwartz, R; Kunkel, L; Siegel, D

Book ID: 118629335
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 85 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70562-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A378 Phase II Study of Carfilzomib in Pa

A378 Phase II Study of Carfilzomib in Patients with Relapsed Myeloma (PX-171-004)

✍ Vij, R; Wang, M; Orlowski, R; Stewart, AK; Jagannath, S; Kukreti, V; Taylor, J; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 109 KB

A493 Phase II Study of Carfilzomib (CFZ)

A493 Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) (PX-171-004)

✍ Vij, R; Wang, M; Orlowski, R; Stewart, AK; Jagannath, S; Kukreti, V; Taylor, J; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 85 KB

An Open-Label Single-Arm Pilot Phase II

An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma

✍ Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, An 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 400 KB

9236 Results of PX-171–003-A0, part 1 of

9236 Results of PX-171–003-A0, part 1 of an open-label, single-arm, phase 2 study of carfilzomib in patients with relapsed and refractory multiple myeloma

✍ Siegel, D.; Vij, R.; Stewart, K.; Somlo, G.; Jakubowiak, A.; Kukreti, V.; Bahlis 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Design and rationale of FOCUS (PX-171-01

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

✍ Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 167 KB

Phase II and pharmacokinetic study of th

Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma

✍ Hirokazu Murakami; Kazuyuki Shimizu; Morio Sawamura; Kenshi Suzuki; Isamu Sugiur 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 207 KB